HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rudi Bao Selected Research

CUDC 305

12/2009Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer.
6/2009CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rudi Bao Research Topics

Disease

12Neoplasms (Cancer)
12/2021 - 02/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2018 - 06/2009
3Ovarian Neoplasms (Ovarian Cancer)
11/2004 - 02/2002
2Lung Neoplasms (Lung Cancer)
02/2018 - 01/2011
1Adenocarcinoma
01/2011
1Colorectal Neoplasms (Colorectal Cancer)
06/2009
1Breast Neoplasms (Breast Cancer)
06/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2009
1Carcinogenesis
08/2003
1Granulosa Cell Tumor
03/2003

Drug/Important Bio-Agent (IBA)

4ErbB Receptors (EGF Receptor)IBA
02/2018 - 12/2009
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2011 - 06/2009
3Pharmaceutical PreparationsIBA
01/2011 - 06/2009
2Histone Deacetylase InhibitorsIBA
12/2021 - 08/2012
2Histone Deacetylases (Histone Deacetylase)IBA
08/2012 - 05/2010
27- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamideIBA
05/2010 - 03/2010
2Phosphotransferases (Kinase)IBA
05/2010 - 12/2009
2CUDC 305IBA
12/2009 - 06/2009
2Proteins (Proteins, Gene)FDA Link
03/2003 - 04/2002
1BEBT-908IBA
12/2021
1Tyrosine Kinase InhibitorsIBA
02/2018
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2012
1CUDC-907IBA
08/2012
1Bevacizumab (Avastin)FDA Link
01/2011
1Anaplastic Lymphoma KinaseIBA
01/2011
1Biomarkers (Surrogate Marker)IBA
01/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2010
1human ERBB2 proteinIBA
05/2010
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2009
1tyrosine receptor (receptor, tyrosine)IBA
12/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2009
1Hormones (Hormone)IBA
11/2004
1GonadotropinsIBA
11/2004
1Estrogens (Estrogen)FDA Link
11/2004
1Progesterone Receptors (Progesterone Receptor)IBA
11/2004
1GATA Transcription FactorsIBA
08/2003
1Tumor Viral Antigens (Large T Antigen)IBA
05/2003
1Cisplatin (Platino)FDA LinkGeneric
03/2003
1Anti-Mullerian HormoneIBA
03/2003
1inhibin-alpha subunitIBA
03/2003
1Alkaline PhosphataseIBA
04/2002
1SurvivinIBA
04/2002
1EnzymesIBA
02/2002
1ProdrugsIBA
02/2002
1LipidsIBA
02/2002

Therapy/Procedure

5Therapeutics
12/2021 - 06/2009
1Immunotherapy
12/2021
1Radiotherapy
02/2018
1Precision Medicine
01/2011